Clinical Criteria for a Pathogen in Term Newborn Suspected of Neonatal Sepsis
IMF-NN
1 other identifier
observational
58
0 countries
N/A
Brief Summary
Neonatal early onset sepsis (EOS) diagnosis is difficult due to lack of sensivity and specificity markers. The investigators conduced a restrospectif study to all term born infants born between 1 january and 31 December 2013 and hospitalized for suspect EOS. The presence of neonatal symptoms at birth appears to be a useful clinical marker of probable neonatal EOS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2017
CompletedFirst Submitted
Initial submission to the registry
August 2, 2018
CompletedFirst Posted
Study publicly available on registry
August 9, 2018
CompletedAugust 9, 2018
August 1, 2018
1.4 years
August 2, 2018
August 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical signs in newborn infants
The objective of the study was to determine early clinical signs in newborn infants with suspected neonatal sepsis to differentiate a likely infection with pathogen bacteria in gastric suction culture.The investigators conduced a retrospective study and all term newborn infant born between 1 january and 31 december 2013 and hospitalized for suspected EOS were included.From the computerized medical file, which is filled in exhaustively, the data were given in the form of continuous values or in the form of a category: maternal age, gestationality, delivery period, delivery method, childbirth administration of maternal antibiotherapy. the parameters at birth were recorded in the same way: sex of the newborn, measurements of birth (birth weight, height, cranial perimeter).
1 year
Study Arms (2)
first group
Observational study of 25 newborn with a likely EOS
second group
Observational study of v33 newborn with a possible EOS
Interventions
Eligibility Criteria
Children born between 1 January and 31 December 2013 and hospitalized in the neonatology department for suspicion of MFIs. Presence of early clinical signs, ie before 72 hours of life.
You may qualify if:
- Children born at the University Hospital Center in Amiens between 1 January and 31 December 2013 and hospitalized in the neonatology department for suspicion of MFIs
You may not qualify if:
- Child born before 37 weeks of amenorrhea and / or having a failure in the birth room requiring immediate transfer to neonatal resuscitation or intensive care neonatology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Tourneux, MD, PhD
CHU AMIENS
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2018
First Posted
August 9, 2018
Study Start
February 21, 2016
Primary Completion
July 12, 2017
Study Completion
July 12, 2017
Last Updated
August 9, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share